Shirkadaha Israa’iil ee Teknolojiyada Caqliga Fudud iyo Bayoolojiyada ayaa ku guuleystay abaalmarinnada ugu sarreeya Shirka Biomed
Afar ka mid ah shirkadaha cusub ee tignoolajiyada caafimaadka ee Israa'iil, oo kala ah Starget Pharma, caVos Biotherapeutics, Protai, iyo BAIBYS, ayaa ku guulaystay abaal-marinnada ugu sarreeya shirka sanadlaha ah ee Biomed Israel 2026.
Yeruusaalem, 17 May, 2026 (TPS-IL) — Afar shirkadood oo Israa‘iili ah oo ka shaqeeya caafimaadka tignoolajiyada ayaa ku guuleystay tartanka shirkadaha bilowga ah ee Biomed Israel 2026, sida ay ku dhawaaqeen dadkii qabanqaabada. Shirka sanadlaha ah, oo lagu qabtay Tel Abiib iyadoo la kaashanayo 8400 The Health Network, ayaa lagu sharfay Starget Pharma, caVos Biotherapeutics, Protai iyo BAIBYS horumarinta tignoolajiyada cusub ee sayniska nolosha.
Starget Pharma waxay horumarisaa daawaynta kansarka ee radioligand, halka caVos Biotherapeutics ay isticmaasho bayoolojiyada horumarka iyo sirdoonka macmal si loo helo daawaynta cudurrada la xiriira da’da. Protai waxay diiradda saartaa daah-furka daawooyinka ee sirdoonka macmalka ah oo bartilmaameedsanaya isku-darka borotiinka ee la xiriira kansarka, BAIBYS waxay samaysay nidaam robotic ah oo awood u leh sirdoonka macmalka ah oo loogu talagalay xulashada shahwada hababka bacriminta vitro.
Ku dhawaad 100 shirkadood ayaa codsaday, waxaana la doortay 12 finalists oo ay soo xuleen garsoorayaal ka socda shirkadaha maalgashiga iyo dawooyinka ee Israa’iil iyo kuwa caalamiga ah.
